Effects of tumor necrosis factor alpha on dendritic cell accumulation in lymph nodes draining the immunization site and the impact on the anticryptococcal cell-mediated immune response

Infection and Immunity

Volumn 71, Issue 1, 2003, Pages 68-74

  Bauman, Sean K ^a   Huffnagle, Gary B ^b   Murphy, Juneann W ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; FUNGUS ANTIGEN; GAMMA INTERFERON; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL COUNT; CELLULAR IMMUNITY; CRYPTOCOCCUS NEOFORMANS; DELAYED HYPERSENSITIVITY; DENDRITIC CELL; FEMALE; FLOW CYTOMETRY; IMMUNIZATION; LANGERHANS CELL; LYMPH NODE; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

ANIMALS; ANTIGENS, FUNGAL; CD4-POSITIVE T-LYMPHOCYTES; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; DENDRITIC CELLS; FEMALE; FLOW CYTOMETRY; FUNGAL VACCINES; HYPERSENSITIVITY, DELAYED; IMMUNITY, CELLULAR; IMMUNIZATION; LYMPH NODES; LYMPHOCYTE ACTIVATION; MICE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0037218146     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.71.1.68-74.2003     Document Type: Article

References (29)

1. Bauman, S. K., K. L. Nichols, and J. W. Murphy. 2000. Dendritic cells in the induction of protective and nonprotective anticryptococcal cell-mediated immune responses. J. Immunol. 165:158-167.
2. Buchanan, K. L., and J. W. Murphy. 1993. Characterization of cellular infiltrates and cytokine production during the expression phase of the anticryptococcal delayed-type hypersensitivity response. Infect. Immun. 61:2854-2865.
3. Buchanan, K. L., and J. W. Murphy. 1997. Kinetics of cellular infiltration and cytokine production during the efferent phase of a delayed-type hypersensitivity reaction. Immunology 90:189-197.
4. Buchanan, K. L., and J. W. Murphy. 1994. Regulation of cytokine production during the expression phase of the anticryptococcal delayed-type hypersensitivity response. Infect. Immun. 62:2930-2939.
5. Casadevall, A., and J. R. Perfect. 1998. Cryptococcus Neoformans. ASM Press, Washington D.C.
6. Cauley, L. K., and J. W. Murphy. 1979. Response of congenitally athymic (nude) and phenotypically normal mice to Cryptococcus neoformans infection. Infect. Immun. 23:644-651.
7. Cumberbatch, M., R. J. Dearman, and I. Kimber. 1997. Langerhans cells require signals from both tumor necrosis factor-α and interleukin-1β for migration. Immunology 92:388-395.
8. Dong, Z. M., and J. W. Murphy. 1995. Intravascular cryptococcal culture filtrate (CneF) and its major component glucuronoxylomannan (GXM) are potent inhibitors of leukocyte accumulation. Infect. Immun. 63:770-778.
9. Doyle, H. A., and J. W. Murphy. 1997. MIP-1α contributes to the anticryptococcal delayed-type hypersensitivity reaction and protection against Cryptococcus neoformans. J. Leukoc. Biol. 61:147-155.
10. Doyle, H. A., and J. W. Murphy. 1999. Role of the C-C chemokine, TCA3, in the protective anticryptococcal cell-mediated immune response. J. Immunol. 162:4824-4833.
11. Geissmann, F., P. Revy, A. Regnault, Y. Lepelletier, M. Dy, N. Brousse, S. H. Amigorena, O., and A. Durandy. 1999. TGF-beta1 prevents the noncognate maturation of human dendritic Langerhans cells. J. Immunol. 162:4567-4575.
12. Graybill, J. R., L. Mitchell, and D. J. Drutz. 1979. Host defense in cryptococcosis III. Protection of nude mice by thymus transplantation. J. Infect. Dis. 140:546-552.
13. Herring, A. C., J. Lee, R. A. McDonald, G. B. Toews, and G. B. Huffnagle. 2002. Induction of interleukin-12 and gamma interferon requires tumor necrosis factor alpha for protective T1-cell-mediated immunity to pulmonary Cryptococcus neoformans infection. Infect. Immun. 70:2959-2964.
14. Hoag, K. A., M. F. Lipscomb, A. A. Izzo, and N. E. Street. 1997. IL-12 and IFN-γ are required for initiating the protective Th1 response to pulmonary cryptococcosis in resistant C.B-17 mice. Am. J. Respir. Cell Mol. Biol. 17: 733-739.
15. Huffnagle, G. B., G. B. Toews, M. D. Burdick, M. B. Boyd, K. S. McAllister, R. A. McDonald, S. L. Kunkel, and R. M. Strieter. 1996. Afferent phase production of TNF-α required for the development of protective T cell immunity to Cryptococcus neoformans. J. Immunol. 157:4529-4536.
16. Janeway, C. A., P. Travers, M. Walport, and M. J. Sholmchik. 2001. Immunobiology. The Immune System in Health and Disease, 5th Ed. Garland Publishing, New York, N.Y.
17. Kovacs, J. A., A. A. Kovacs, M. Polis, W. C. Wright, V. J. Gill, C. U. Tuazon, E. P. Gelmann, H. C. Lane, R. Longfield, G. Overturf, A. M. Macher, A. S. Fauci, J. E. Parrillo, J. E. Bennett, and H. Masur. 1985. Cryptococcosis in the acquired immunodeficiency syndrome. Ann. Intern. Med. 103:533-538.
18. Mitchell, T. G., and J. R. Perfect. 1995. Cryptococcosis in the era of AIDS: 100 Years after the discovery of Cryptococcus neoformans. Clin. Microbiol. Rev. 8:515-548.
19. Murphy, J. W. 1999. Cell-mediated immunity and medically related fungi, p. 593-621. In M. W. Cunningham, and R. S. Fujinami (ed.), Effects of microbes on the immune system. Lippincott Williams & Wilkins, Philadelphia, Pa.
20. Murphy, J. W. 1993. Cytokine profiles associated with induction of the anticryptococcal cell-mediated immune response. Infect. Immun. 61:4750-4759.
21. Murphy, J. W. 1998. Protective cell-mediated immunity against Cryptococcus neoformans. Res. Immunol. 149:373-386.
22. Murphy, J. W., and R. L. Mosley. 1985. Regulation of cell-mediated immunity in cryptococcosis. III. Characterization of second-order T suppressor cells (Ts2). J. Immunol. 134:577-584.
23. Murphy, J. W., F. Schafer, A. Casadevall, and A. Adesina. 1998. Antigen-induced protective and non-protective cell-mediated immune components against Cryptococcus neoformans. Infect. Immun. 66:2632-2639.
24. Muth, S. M., and J. W. Murphy. 1995. Direct anticryptococcal activity of lymphocytes from Cryptococcus neoformans-immunized mice. Infect. Immun. 63:1637-1644.
25. Nichols, K. L., S. K. Bauman, F. B. Schafer, and J. W. Murphy. 2002. Differences in components at the delayed-type hypersensitivity (DH) reaction sites in mice immunized with either a protective or a nonprotective immunogen of Cryptococcus neoformans. Infect. Immun. 70:591-600.
26. Piguet, P. F., G. E. Grau, C. Hauser, and P. Vassalli. 1991. Tumor necrosis factor is a critical mediator in hapten-induced irritant and contract hypersensitivity reactions. J. Exp. Med. 173:673-679.
27. Salomon, B., J. L. Cohen, C. Masurier, and D. Klatzmann. 1998. Three populations of mouse lymph node DC with different origins and dynamics. J. Immunol. 160:708-717.
28. Vremec, D., and K. Shortman. 1997. Dendritic cell subtypes in mouse lymphoid organs cross-correlation of surface markers, changes with incubation, and differences among thymus, spleen, and lymph nodes. J. Immunol. 159:565-573.
29. Yuan, R. R., A. Casadevall, J. Oh, and M. D. Scharff. 1997. T cells cooperate with passive antibody to modify Cryptococcus neoformans infection in mice. Proc. Natl. Acad. Sci. USA 94:2483-2488.